Kocgozlu Leyla, Mutschler Angela, Tallet Lorène, Calligaro Cynthia, Knopf-Marques Helena, Lebaudy Eloïse, Mathieu Eric, Rabineau Morgane, Gribova Varvara, Senger Bernard, Vrana N Engin, Lavalle Philippe
Institut National de la Santé et de la Recherche Médicale, UMR_S 1121, Strasbourg, France.
Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France.
Mater Today Bio. 2024 Aug 2;28:101168. doi: 10.1016/j.mtbio.2024.101168. eCollection 2024 Oct.
Postoperative infections are the most common complications faced by surgeons after implant surgery. To address this issue, an emerging and promising approach is to develop antimicrobial coatings using antibiotic substitutes. We investigated the use of polycationic homopolypeptides in a layer-by-layer coating combined with hyaluronic acid (HA) to produce an effective antimicrobial shield. The three peptide-based polycations used to make the coatings, poly(l-arginine) (PAR), poly(l-lysine), and poly(l-ornithine), provided an efficient antibacterial barrier by a contact-killing mechanism against Gram-positive, Gram-negative, and antibiotic-resistant bacteria. Moreover, this activity was higher for homopolypeptides containing 30 amino-acid residues per polycation chain, emphasizing the impact of the polycation chain length and its mobility in the coatings to deploy its contact-killing antimicrobial properties. However, the PAR-containing coating emerged as the best candidate among the three selected polycations, as it promoted cell adhesion and epithelial monolayer formation. It also stimulated nitric oxide production in endothelial cells, thereby facilitating angiogenesis and subsequent tissue regeneration. More interestingly, bacteria did not develop a resistance to PAR and (PAR/HA) also inhibited the proliferation of eukaryotic pathogens, such as yeasts. Furthermore, investigations on a (PAR/HA)-coated hernia mesh implanted on a rabbit model confirmed that the coating had antibacterial properties without causing chronic inflammation. These impressive synergistic activities highlight the strong potential of PAR/HA coatings as a key tool in combating bacteria, including those resistant to conventional antibiotics and associated to medical devices.
术后感染是植入手术后外科医生面临的最常见并发症。为了解决这个问题,一种新兴且有前景的方法是使用抗生素替代品开发抗菌涂层。我们研究了在与透明质酸(HA)结合的层层涂层中使用聚阳离子均聚物多肽来产生有效的抗菌屏障。用于制备涂层的三种基于肽的聚阳离子,聚(L-精氨酸)(PAR)、聚(L-赖氨酸)和聚(L-鸟氨酸),通过接触杀灭机制对革兰氏阳性菌、革兰氏阴性菌和耐抗生素细菌提供了有效的抗菌屏障。此外,每条聚阳离子链含有30个氨基酸残基的均聚物多肽的这种活性更高,这强调了聚阳离子链长度及其在涂层中的流动性对发挥其接触杀灭抗菌性能的影响。然而,含PAR的涂层在所选的三种聚阳离子中脱颖而出,成为最佳候选者,因为它促进细胞粘附和上皮单层形成。它还刺激内皮细胞产生一氧化氮,从而促进血管生成和随后的组织再生。更有趣的是,细菌不会对PAR产生抗性,并且(PAR/HA)还能抑制真核病原体(如酵母)的增殖。此外,对植入兔模型的(PAR/HA)涂层疝修补网的研究证实,该涂层具有抗菌性能且不会引起慢性炎症。这些令人印象深刻的协同活性突出了PAR/HA涂层作为对抗细菌(包括那些对传统抗生素耐药且与医疗器械相关的细菌)的关键工具的强大潜力。